Microfluidic Exosome Analysis toward Liquid Biopsy for Cancer

Area of Science:

• Biomedical Engineering
• Molecular Oncology
• Nanotechnology

Background:

• Liquid biopsy enables noninvasive cancer monitoring by analyzing biofluid samples.
• Circulating exosomes are valuable tumor surrogates, carrying essential biomarkers like proteins, RNAs, and DNA.
• Exosome purification and characterization present significant technical challenges.

Purpose of the Study:

• To review state-of-the-art microfluidic technologies for exosome isolation and molecular characterization.
• To highlight the applications of these microfluidic technologies in liquid biopsy for cancer analysis.
• To discuss current challenges and future directions in microfluidic exosome analysis.

Main Methods:

• Review of microfluidic lab-on-a-chip technologies for exosome analysis.
• Focus on integration, automation, enhanced sensing, and expedited analysis.
• Emphasis on applications in cancer liquid biopsy.

Main Results:

• Microfluidic technologies effectively address challenges in exosome purification and characterization.
• These technologies offer advantages in integration, automation, and sensing performance.
• Significant advancements in microfluidic applications for cancer liquid biopsy are presented.

Conclusions:

• Microfluidic technologies are crucial for advancing exosome-based liquid biopsy in cancer.
• Continued development is needed to overcome current challenges and optimize exosome analysis.
• Future directions include further integration and automation for enhanced clinical utility.